Article Text
Abstract
We report a unique, collaborative effort by users and providers of genetic services to arrive at outlines for optimal ethics and clinical practice. Using focus groups of consumers (users) and providers (held separately), a provider-consumer project team developed 1) a consumer wish list, 2) an experientially based ethical overview of situations arising in practice, and 3) detailed suggestions for consumer-provider interactions in clinical settings. Consumers were primarily interested in accurate information, respect for persons, a smoothly functioning team, with the consumer as an equal member of the team, family integrity, and providers who knew the limits of their knowledge and were willing to refer. “Non-directive” counselling and privacy were not major issues in consumer focus groups; some thought providers should openly state their own opinions. Providers had a rather different list of priorities.
Books and papers on clinical ethics usually originate from bioethicists and physicians. This pilot project is unique in including consumers and providers equally.
- Genetic services
- genetics and ethics
- consumer-provider interaction
- genetics and policy
Statistics from Altmetric.com
Footnotes
-
Dorothy C Wertz, PhD, is Senior Scientist in Social Science, Ethics and Law, The Shriver Center for Mental Retardation, Waltham, MA,USA. Robin Gregg PhD, was formerly a postdoctoral fellow at the Shriver Center.
Read the full text or download the PDF:
Other content recommended for you
- Genetic testing and reproductive choice in neurological disorders
- Exceptional know how? Possible pitfalls of routinising genetic services
- Primary prevention of neurological illness early in life
- The challenge of integrating genetic medicine into primary care
- Understanding of and attitudes to genetic testing for inherited retinal disease: a patient perspective
- Clinical geneticists' attitudes and practice towards testing for breast cancer susceptibility genes
- Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC)
- Predictive genetic testing for neurodegenerative conditions: how should conflicting interests within families be managed?
- Reproductive choices and intrafamilial communication in neurogenetic diseases with different self-estimated severities
- Lessons from predictive testing for Huntington disease: 25 years on